Arecor Therapeutics PLC (LSE:AREC)
£ 1.59 0.015 (0.95%) Market Cap: 48.70 Mil Enterprise Value: 42.28 Mil PE Ratio: 0 PB Ratio: 5.11 GF Score: 47/100

Half Year 2024 Arecor Therapeutics PLC Earnings Presentation (Q&A) Transcript

Sep 20, 2023 / 01:00PM GMT
Release Date Price: £1.93
Operator

Presentation (Q&A)
Sep 20, 2023 / 01:00PM GMT

=====================
Corporate Participants
=====================
* Sarah Jennifer Howell
Arecor Therapeutics plc - CEO & Director
* Susan Day Lowther
Arecor Therapeutics plc - CFO, Company Secretary & Director

=====================

Sarah Jennifer Howell
Arecor Therapeutics plc - CEO & Director

Good afternoon, ladies and gentlemen, and welcome to the Arecor Therapeutics plc Interim Results Investor Presentation. (Operator Instructions). The company may not be in a position to answer every question it receives during the meeting itself. However, the company will review all questions submitted today and publish responses where it's appropriate do so and these will be available via your Investor Meet company dashboard. Before we begin, I would like to submit the following poll.

And I would now like to hand you over to CEO, Sarah Howell. Good afternoon, Sarah.

-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot